全文获取类型
收费全文 | 2611篇 |
免费 | 57篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 91篇 |
儿科学 | 37篇 |
妇产科学 | 19篇 |
基础医学 | 398篇 |
口腔科学 | 51篇 |
临床医学 | 165篇 |
内科学 | 521篇 |
皮肤病学 | 43篇 |
神经病学 | 215篇 |
特种医学 | 76篇 |
外科学 | 462篇 |
综合类 | 16篇 |
预防医学 | 48篇 |
眼科学 | 37篇 |
药学 | 237篇 |
中国医学 | 5篇 |
肿瘤学 | 253篇 |
出版年
2023年 | 5篇 |
2022年 | 7篇 |
2021年 | 37篇 |
2020年 | 20篇 |
2019年 | 19篇 |
2018年 | 29篇 |
2017年 | 23篇 |
2016年 | 29篇 |
2015年 | 28篇 |
2014年 | 54篇 |
2013年 | 96篇 |
2012年 | 149篇 |
2011年 | 167篇 |
2010年 | 83篇 |
2009年 | 97篇 |
2008年 | 134篇 |
2007年 | 178篇 |
2006年 | 173篇 |
2005年 | 190篇 |
2004年 | 185篇 |
2003年 | 211篇 |
2002年 | 198篇 |
2001年 | 50篇 |
2000年 | 42篇 |
1999年 | 35篇 |
1998年 | 54篇 |
1997年 | 42篇 |
1996年 | 35篇 |
1995年 | 34篇 |
1994年 | 29篇 |
1993年 | 17篇 |
1992年 | 20篇 |
1991年 | 20篇 |
1990年 | 18篇 |
1989年 | 29篇 |
1988年 | 12篇 |
1987年 | 14篇 |
1986年 | 6篇 |
1985年 | 17篇 |
1984年 | 13篇 |
1983年 | 11篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1980年 | 11篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 4篇 |
1974年 | 5篇 |
1967年 | 2篇 |
排序方式: 共有2674条查询结果,搜索用时 15 毫秒
991.
Hirata Y Ohmae T Yanai A Sakitani K Hayakawa Y Yoshida S Sugimoto T Mitsuno Y Akanuma M Yamaji Y Ogura K Maeda S Koike K 《International journal of antimicrobial agents》2012,39(4):352-355
The third-line treatment regimen for Helicobacter pylori after failure of clarithromycin- and metronidazole-based therapies is not yet established. Sitafloxacin (STX) is a quinolone that possesses potent in vitro activity against H. pylori. In this study, the susceptibility of H. pylori isolates to STX was examined and the efficacy of STX-based triple therapy as a third-line regimen was evaluated. STX showed minimum inhibitory concentrations (MICs) of ≤1 μg/mL against all 100 H. pylori isolates, and the MIC(90) (MIC for 90% of the organisms) of STX was 5 log(2) dilutions lower than that of levofloxacin (LVX). The MIC(50) (MIC for 50% of the organisms) of STX against gyrA mutants was 0.12 μg/mL and was significantly lower than that of LVX (8 μg/mL). The activity of STX at pH 5.5 was significantly less than that at pH 7.0. In the clinical trial, 28 patients with two eradication failures were treated with STX-based triple therapy [rabeprazole 10 mg twice daily (b.i.d.), amoxicillin 750 mg b.i.d. and STX 100mg b.i.d. for 7 days]. The eradication rate was 75% using intention-to-treat analysis and 80% using per-protocol analysis. Two gyrA mutant strains were eradicated. Amongst participants, a low pepsinogen I/II ratio was associated with successful eradication. These results suggest that STX could be active against most clinical H. pylori isolates and that STX-based triple therapy is a promising and safe third-line therapy. 相似文献
992.
Wang Q Liu M Liu WW Hao WB Tashiro S Onodera S Ikejima T 《Journal of Asian natural products research》2012,14(5):413-423
Improper adjustments of autophagy and silent information regulator 1 (Sirt-1) expression were reported to be closely associated with metabolic disorders. In this study, we examined the roles of Sirt-1 and autophagy in streptozotocin-induced diabetes mellitus, assessed the relationship between autophagy and Sirt-1, and investigated the protective mechanism of silibinin. Diabetes was induced in 6-week-old mice by intravenous injection of streptozotocin (150?mg/kg/day, for 2 weeks). In the treatment groups, silibinin (50?mg/kg/day, intramuscular injection, for 8 weeks) or inhibitors (50?mg/kg/day, subcutaneous injection, for 8 weeks) were given. Diabetic control animals received vehicle for the same time. Compared with diabetic controls, silibinin or autophagy inhibitor, 3-methyladenine, treated mice showed decreased levels of glycosylated hemoglobin A1C (P?0.01), serum triglyceride (P?0.01), cholesterol (P?0.01), blood glucose (P?0.05), autophagy (P?0.05), and apoptosis ratio (P?0.05) of pancreatic β-cells. Systemic administration of silibinin reversed streptozotocin-induced downregulation of Sirt-1 expression. Sirt-1 may play a role in regulating the physiological level of autophagy and is associated with loss of pancreatic β-cells and metabolic biochemical disorders. Through promoting Sirt-1 expression and recovering autophagy physiologically, silibinin may reverse hyperglycemia and repair damaged pancreatic β-cells. 相似文献
993.
Wang Q Ye Y Liu W Jiang S Tashiro S Onodera S Gu F Wang Y Ikejima T 《Journal of Asian natural products research》2012,14(7):688-699
Skin inflammation induced by ultraviolet B (UVB) radiation is characterized by migration and chemotaxis of inflammatory cells, epidermic thickening and erythema. Apoptosis and autophagy of epidermal and dermal cells are involved in its development through the adjustment of balance between cell survival and death. In this study, the role of balance between cell survival and apoptosis in dermis and epidermis in UVB-induced skin inflammation and the effect of autophagy on the balance were elucidated, and the protective mechanism of silibinin was investigated through the examination of the influence of autophagy activation or inhibition on erythema, migration, and chemotaxis of inflammatory cells as well as apoptosis adjustments. In UVB-irradiated controls, dermal apoptosis was retarded and the survival of inflammatory cells was promoted through the up-regulation of dermal autophagic level; epidermal apoptosis was increased through the down-regulation of epidermal autophagic level, causing migration and chemotaxis of neutrophils and mast cells as well as skin erythema. In silibinin-treated group (50?mg/kg/day for 4 days), dermal apoptosis was increased through inhibiting dermal autophagy; improper adjustment of epidermal apoptosis was attenuated through promoting epidermal autophagy, presenting dual effects on the balance between autophagy and apoptosis of epidermal and dermal cells and the protection. 相似文献
994.
995.
Hong-Jun Wang Dan Li Fan-Yi Yang Shin-ichi Tashiro Satoshi Onodera 《Journal of Asian natural products research》2013,15(8):777-788
Our previous studies indicated that oridonin, a diterpenoid isolated from Rabdosia rubescens, induced human melanoma A375-S2 cell apoptosis. In this study, we investigated whether the proapoptotic effect of oridonin on A375-S2 cells would depend on an interference with function of the insulin-like growth factor 1 (IGF-1) receptor, a plasma membrane receptor critical for the survival or antiapoptotic ability in melanoma cells. We found that IGF-1 receptor (IGF-1R) signaling was a potential survival pathway against a low concentration of 20 μmol/L oridonin-induced apoptosis in A375-S2 cells. The activation of Ras or its downstream effector p38 mitogen-activated protein kinase (p38 MAPK) was shown to be necessary for IGF-1-mediated protection, but the activation of phosphatidylinositol-3-OH kinase (PI3 kinase) or extracellular signal-regulated kinase (ERK) did not correlate with the regulation of survival. However, in the presence of 40 μmol/L (IC50 at 24 h) oridonin, A375-S2 cells could not be protected by IGF-1 from apoptosis, accompanied by a severe impairment of IGF-1R expression. Therefore, we concluded that the proapoptotic activity of oridonin was partially attributed to its repression of IGF-1R signaling. In addition, p53 was supposed to be a pivotal transducer of proapoptotic and survival signaling pathway in this system. 相似文献
996.
Min Qi Simiao Fan Guodong Yao Zhao Li Haiyan Zhou Shin-ichi Tashiro Satoshi Onodera Mingyu Xia Takashi Ikejima 《Journal of pharmacological sciences》2013,121(3):200-211
Pseudolaric acid B (PAB) is the primary biologically active compound isolated from the root bark of P. kaempferi Gordon. Our previous study demonstrated that PAB induced mitotic catastrophe in L929 cells and indicated that only a small percentage (12%) of the cells undergoing mitotic catastrophe displayed an apoptotic phenotype after PAB treatment for 72 h. In this study, we found that a minority of the cells undergoing mitotic catastrophe ended in apoptosis, and a majority of them entered a period of senescence. Further data confirmed that PAB induced autophagy, reactive oxygen species (ROS) generation, and mitochondrial dysfunction in L929 cells. Subsequently, we found that autophagy inhibitors significantly delayed the senescence process, indicating that autophagy facilitated senescence. Moreover, ROS scavenger significantly decreased the autophagic level and improved mitochondrial function. Additionally, autophagy inhibitors effectively reduced ROS levels and ameliorated mitochondrial function. In conclusion, autophagy promoted senescence via enhancement of ROS generation and mitochondrial dysfunction in PAB-treated L929 cells. 相似文献
997.
Yuka Isozaki Isamu Hoshino Yasunori Akutsu Aki Akimoto Naoki Akanuma Nobuyoshi Takeshita Tetsuro Maruyama Hisahiro Matsubara 《Esophagus》2013,10(2):79-85
Background
The purpose of this research is to determine the correlation between IGFBP-4/IGF-I expression and the clinical status of esophageal squamous cell carcinoma (ESCC).Materials and methods
Immunohistochemical staining for IGFBP-4 and IGF-I was performed in 61 clinical samples. The correlation between IGFBP-4/IGF-I staining and clinicopathological features was examined statistically. In addition, we compared the mRNA expression levels of IGFBP-4 and IGF-I between ESCC cancer tissues and the normal esophageal epithelium using a quantitative real-time RT-PCR.Results
According to the results of immunohistochemical staining, IGFBP-4 expression in the region of normal epithelial cells showed an increase of 52.5 % compared to expression in the tumor cells. There was no statistically significant correlation between IGFBP-4/IGF-I and clinicopathological features. The correlation between IGF-I and IGFBP-4 was not significant either. RT-PCR assay showed IGF-I expression in ESCC tissue has a tendency to be higher than that of normal esophageal epithelium. On the other hand, IGFBP-4 expression levels in cancer tissue were lower in comparison with normal epithelium. These results were not significant.Conclusions
There were the differences of IGFBP-4 expression between the region of ESCC and the region of normal epithelium cells. One suggested possibility is that IGF-independent action of IGFBP-4 might have taken part in these results. We need further exploratory experiments to elucidate the details of the actual function of IGFBP-4 expression in ESCC. 相似文献998.
Toru Hanamura Toshifumi Niwa Sayo Nishikawa Hiromi Konno Tatsuyuki Gohno Chika Tazawa Yasuhito Kobayashi Masafumi Kurosumi Hiroyuki Takei Yuri Yamaguchi Ken-ichi Ito Shin-ichi Hayashi 《Breast cancer research and treatment》2013,139(3):731-740
Aromatase inhibitors (AIs) have been reported to exert their antiproliferative effects in postmenopausal women with hormone receptor-positive breast cancer not only by reducing estrogen production but also by unmasking the inhibitory effects of androgens such as testosterone (TS) and dihydrotestosterone (DHT). However, the role of androgens in AI-resistance mechanisms is not sufficiently understood. 5α-Androstane-3β,17β-diol (3β-diol) generated from DHT by 3β-hydroxysteroid dehydrogenase type 1 (HSD3B1) shows androgenic and substantial estrogenic activities, representing a potential mechanism of AI resistance. Estrogen response element (ERE)-green fluorescent protein (GFP)-transfected MCF-7 breast cancer cells (E10 cells) were cultured for 3 months under steroid-depleted, TS-supplemented conditions. Among the surviving cells, two stable variants showing androgen metabolite-dependent ER activity were selected by monitoring GFP expression. We investigated the process of adaptation to androgen-abundant conditions and the role of androgens in AI-resistance mechanisms in these variant cell lines. The variant cell lines showed increased growth and induction of estrogen-responsive genes rather than androgen-responsive genes after stimulation with androgens or 3β-diol. Further analysis suggested that increased expression of HSD3B1 and reduced expression of androgen receptor (AR) promoted adaptation to androgen-abundant conditions, as indicated by the increased conversion of DHT into 3β-diol by HSD3B1 and AR signal reduction. Furthermore, in parental E10 cells, ectopic expression of HSD3B1 or inhibition of AR resulted in adaptation to androgen-abundant conditions. Coculture with stromal cells to mimic local estrogen production from androgens reduced cell sensitivity to AIs compared with parental E10 cells. These results suggest that increased expression of HSD3B1 and reduced expression of AR might reduce the sensitivity to AIs as demonstrated by enhanced androgen metabolite-induced ER activation and growth mechanisms. Androgen metabolite-dependent growth of breast cancer cells may therefore play a role in AI-resistance. 相似文献
999.
N Takeshita I Hoshino M Mori Y Akutsu N Hanari Y Yoneyama N Ikeda Y Isozaki T Maruyama N Akanuma A Komatsu M Jitsukawa H Matsubara 《British journal of cancer》2013,108(3):644-652
Background:
Recent studies have demonstrated that microRNAs (miRNAs) are stably detectable in blood and can serve as useful biomarkers for cancer.Methods:
We performed an miRNA array using serum samples obtained from oesophageal squamous cell carcinoma (ESCC) patients or healthy controls. MiR-1246 was the most markedly elevated in ESCC patients. Therefore, miR-1246 was selected as a candidate for further analysis. The serum miR-1246 level in 46 healthy controls and 101 ESCC patients was evaluated and compared among various clinicopathological characteristics. MiR-1246 expressions in tissue, exosomal, and cellular samples were also examined.Results:
Serum miR-1246 alone yielded an receiver-operating characteristic curve area of 0.754, with 71.3% sensitivity and 73.9% specificity for distinguishing ESCC patients from healthy controls. Serum miR-1246 was significantly correlated with the TNM stage and showed to be the strongest independent risk factor for poor survival (HR, 4.032; P=0.017). Unlike the tendency shown in previous reports, miR-1246 was not upregulated in ESCC tissue samples. Furthermore, exosomal miR-1246 did not reflect the abundance in the cell of origin.Conclusion:
These data support our contention that serum miR-1246 has strong potential as a novel diagnostic and prognostic biomarker in ESCC, and its releasing mechanism is selective and independent of tissue miRNA abundance. 相似文献1000.
Terui K Iwai J Yamada S Takenouchi A Nakata M Komatsu S Yoshida H 《Pediatric surgery international》2012,28(1):9-14